Company intelligence
QVance
Quality analytics by drug developers for drug developers
Research Services
Stockholm, SE
2–10 employees
Founded 2024
4 public signals
About QVance
QVance is an innovative start up focused on the provision of quality control (QC) analytics for the advanced therapy market. Developed by drug developers for drug developers the mission of the company is to be a one-stop shop for QC analytics, supporting developers across the full product lifecycle. We are committed to providing a personal service with bespoke support, helping developers from product inception through to commercialisation.
Verified activity
Signals from QVance
4 published signals
Presence & Recognition
QVance's CEO Lindsay Davies will be attending Phacilitate's ATE event in Barcelona next week.
Reported by QVance
Presence & Recognition
QVance is attending the panel discussion on how to rethink QC and turn bottlenecks into opportunities with Charlotte Serra-Maisonneuve, PhD, MBA, and Stefano Baila.
Reported by Lindsay Davies
Presence & Recognition
QVance is attending the WIAT pre-conference meeting on Monday with Becky Johnson-Kent and Laura Koivusalo to discuss building, funding, and leading companies in CGTs.
Reported by Lindsay Davies